Literature DB >> 30324645

Crystal structure and anti-inflammatory and anaphylactic effects of andrographlide sulphonate E in Xiyanping, a traditional Chinese medicine injection.

Qian-Wen Yang1, Qiao Li1, Jie Zhang1, Qian Xu1, Xin Yang2, Zhi-Yong Li3, Hui Xu1.   

Abstract

OBJECTIVES: Andrographlide sulphonate E, namely sodium 9-dehydro-17-hydro-andrographolide-19-yl sulphate, was one of the major ingredients of Xiyanping injection. The present study aimed to demonstrate its suitability as a reference standard for use of quality control of this traditional Chinese medicine preparation made from andrographlide that has been widely used to treat various infectious diseases.
METHODS: The stable crystals were prepared for unambiguous elucidation of the chemical structure by comprehensive spectral and thermal analysis. The anti-inflammatory effects were investigated using in vitro and in vivo methods, and the potential allergenic risk related with safety was evaluated by in silico molecular docking analysis. KEY
FINDINGS: The dihydrated sulphonate derivative could be present as orthorhombic crystals with stable three-dimensional supramolecular structure, providing it the favourable physico-chemical stability as reference substance. It exhibited potent anti-inflammatory activity both in vitro and in vivo, suggesting the potency responsible for clinic efficacy of Xiyanping. Molecular docking further demonstrated its low risk of allergic reaction, as well as the proposed mechanism of anaphylactic effect of andrographolide analogues.
CONCLUSIONS: Dihydrated sodium 9-dehydro-17-hydro-andrographolide-19-yl sulphate may be the ideal reference standard for use in quality control of Xiyanping.
© 2018 Royal Pharmaceutical Society.

Entities:  

Keywords:  anaphylactic effect; andrographolide derivatives; anti-inflammatory activities; crystal structure; sulphonation modification

Mesh:

Substances:

Year:  2018        PMID: 30324645     DOI: 10.1111/jphp.13028

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  Efficacy and safety of Xiyanping injection in the treatment of COVID-19: A multicenter, prospective, open-label and randomized controlled trial.

Authors:  Xin-Yi Zhang; Lang Lv; Yu-Long Zhou; Liang-Dong Xie; Qin Xu; Xiao-Fan Zou; Yan Ding; Jie Tian; Jia-Liang Fan; Hai-Wei Fan; Yi-Xi Yang; Xiao-Qun Ye
Journal:  Phytother Res       Date:  2021-05-12       Impact factor: 6.388

Review 2.  Xiyanping Plus Azithromycin Chemotherapy in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Authors:  Qiao Li; Zhi-Yong Li; Jie Zhang; Wen-Na Guo; Xiao-Meng Xu; Fa-Xin Sun; Hui Xu
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-29       Impact factor: 2.629

Review 3.  The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence.

Authors:  Dan Zhang; Bing Zhang; Jin-Tao Lv; Ri-Na Sa; Xiao-Meng Zhang; Zhi-Jian Lin
Journal:  Pharmacol Res       Date:  2020-05-05       Impact factor: 7.658

4.  Combination Therapy with TCM Preparation Kumu Injection and Azithromycin against Bacterial Infection and Inflammation: In Vitro and In Vivo.

Authors:  Meiyu Yu; Xuejing Gu; Yanzheng Qu; Fuyou Sun; Yanli Li; Feng Zhao; Hui Xu
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-16       Impact factor: 2.629

Review 5.  Medicinal Plants with Potential Inhibitory Bioactive Compounds against Coronaviruses.

Authors:  Olutayo Ademola Adeleye; Oluyemisi Adebowale Bamiro; Lateef Gbenga Bakre; Florence Olubola Odeleye; Modupe Nofisat Adebowale; Olufemi Lionel Okunye; Mariam Adeola Sodeinde; Adannaya Charity Adebona; Farid Menaa
Journal:  Adv Pharm Bull       Date:  2021-01-30

6.  Xiyanping injection combined with acitretin for psoriasis vulgaris: A systematic review and meta-analysis.

Authors:  Man-Ning Wu; Li-Jia-Ming Zhou; Dong-Mei Zhou
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

Review 7.  The therapeutic effects of traditional chinese medicine on COVID-19: a narrative review.

Authors:  Can Wang; Shusen Sun; Xuansheng Ding
Journal:  Int J Clin Pharm       Date:  2020-09-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.